These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34673106)

  • 1. Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19.
    Rabbani G; Ahn SN
    Int J Biol Macromol; 2021 Dec; 193(Pt A):948-955. PubMed ID: 34673106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
    Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
    Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low plasma angiotensin-converting enzyme 2 level in diabetics increases the risk of severe COVID-19 infection.
    Zhang Y; Sun Y; Liu K; Alolga RN; Xu X; Feng G; Xiao P
    Aging (Albany NY); 2021 May; 13(9):12301-12307. PubMed ID: 33962399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
    Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
    Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ACE2 species are differentially altered in COVID-19 patients.
    García-Ayllón MS; Moreno-Pérez O; García-Arriaza J; Ramos-Rincón JM; Cortés-Gómez MÁ; Brinkmalm G; Andrés M; León-Ramírez JM; Boix V; Gil J; Zetterberg H; Esteban M; Merino E; Sáez-Valero J
    FASEB J; 2021 Aug; 35(8):e21745. PubMed ID: 34191346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
    Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
    Elife; 2022 Nov; 11():. PubMed ID: 36416537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients.
    Kragstrup TW; Singh HS; Grundberg I; Nielsen AL; Rivellese F; Mehta A; Goldberg MB; Filbin MR; Qvist P; Bibby BM
    PLoS One; 2021; 16(6):e0252799. PubMed ID: 34086837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.
    Fuchs E; Rudnik-Jansen I; Dinesen A; Selnihhin D; Mandrup OA; Thiam K; Kjems J; Pedersen FS; Howard KA
    Acta Biomater; 2022 Nov; 153():411-418. PubMed ID: 36162760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated miR-200c is associated with downregulation of the functional receptor for severe acute respiratory syndrome coronavirus 2 ACE2 in individuals with obesity.
    Bellae Papannarao J; Schwenke DO; Manning P; Katare R
    Int J Obes (Lond); 2022 Jan; 46(1):238-241. PubMed ID: 34625660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
    Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
    Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.
    Butler-Laporte G; Nakanishi T; Mooser V; Renieri A; Amitrano S; Zhou S; Chen Y; Forgetta V; Richards JB
    Int J Epidemiol; 2021 Mar; 50(1):75-86. PubMed ID: 33349849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
    Nagy B; Fejes Z; Szentkereszty Z; Sütő R; Várkonyi I; Ajzner É; Kappelmayer J; Papp Z; Tóth A; Fagyas M
    Int J Infect Dis; 2021 Feb; 103():412-414. PubMed ID: 33249290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.
    Bank S; De SK; Bankura B; Maiti S; Das M; A Khan G
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33442728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
    Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
    J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.